Zeltiq Aesthetics Inc  

(Public, NASDAQ:ZLTQ)   Watch this stock  
Find more results for Zeltiq Aesthetics Inc´┐Ż
31.76
-0.29 (-0.90%)
Mar 5 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 31.56 - 32.34
52 week 13.30 - 35.90
Open 32.06
Vol / Avg. 0.00/620,216.00
Mkt cap 1.21B
P/E     -
Div/yield     -
EPS -0.16
Shares 37.85M
Beta -0.08
Inst. own 99%
Apr 27, 2015
Q1 2015 ZELTIQ Aesthetics Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Mar 12, 2015
ZELTIQ Aesthetics Inc at Barclays Healthcare Conference - 10:15AM EDT - Add to calendar
Mar 9, 2015
ZELTIQ Aesthetics Inc at ROTH Conference - 1:30PM EDT - Add to calendar
Mar 3, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Call
Mar 3, 2015
Q4 2014 ZELTIQ Aesthetics Inc Earnings Release
Feb 18, 2015
ZELTIQ Aesthetics Inc at BTIG Snowbird Conference
Feb 11, 2015
ZELTIQ Aesthetics Inc at Leerink Global Healthcare Conference
Jan 14, 2015
ZELTIQ Aesthetics Inc at JPMorgan Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 10.47% -17.29%
Operating margin 10.87% -17.33%
EBITD margin - -15.78%
Return on average assets 21.03% -21.65%
Return on average equity 29.61% -28.57%
Employees 297 -
CDP Score - -

Address

4698 Willow Rd Ste 100
PLEASANTON, CA 94588-2806
United States - Map
+1-925-4742500 (Phone)
+1-925-4742599 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Zeltiq Aesthetics, Inc. operates as a medical device development company. It engages in the design, development, and commercialization of non-invasive procedures for the reduction of unwanted fat tissue. It develops Cryolipolysis, a technology that enables the reduction of fat tissue near nerves, muscle, and bones. The Company develops a non-invasive technology for aesthetic applications and plastic surgery. Its product is used as a skin cooling device to minimize pain and thermal injury during laser and dermatological treatments.

Officers and directors

Mark J. Foley President, Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Patrick Williams Chief Financial Officer, Senior Vice President
Age: 41
Bio & Compensation  - Reuters
Sergio Garcia-Rodriguez Senior Vice President, General Counsel and Corporate Secretary
Age: 52
Bio & Compensation  - Reuters
Keith Sullivan Senior Vice President of Worldwide Sales
Age: 56
Bio & Compensation  - Reuters
Len DeBenedictis Chief Technology Officer
Age: 73
Bio & Compensation  - Reuters
Carl H Lamm Vice President of Operations
Age: 52
Bio & Compensation  - Reuters
Mary M. Fisher Director
Age: 52
Bio & Compensation  - Reuters
D. Keith Grossman Director
Age: 55
Bio & Compensation  - Reuters
Jean M. George Independent Director
Age: 56
Bio & Compensation  - Reuters
Kevin C. O'Boyle CPA Independent Director
Age: 59
Bio & Compensation  - Reuters